216 related articles for article (PubMed ID: 23638073)
1. Comparative analysis of the gut microbiota in people with different levels of ginsenoside Rb1 degradation to compound K.
Kim KA; Jung IH; Park SH; Ahn YT; Huh CS; Kim DH
PLoS One; 2013; 8(4):e62409. PubMed ID: 23638073
[TBL] [Abstract][Full Text] [Related]
2. Effects of broad-spectrum antibiotics on the metabolism and pharmacokinetics of ginsenoside Rb1: a study on rats׳ gut microflora influenced by lincomycin.
Xu R; Peng Y; Wang M; Fan L; Li X
J Ethnopharmacol; 2014 Dec; 158 Pt A():338-44. PubMed ID: 25446586
[TBL] [Abstract][Full Text] [Related]
3. Metabolism of ginsenoside Rb1 by human intestinal microflora and cloning of its metabolizing β-D-glucosidase from Bifidobacterium longum H-1.
Jung IH; Lee JH; Hyun YJ; Kim DH
Biol Pharm Bull; 2012; 35(4):573-81. PubMed ID: 22466563
[TBL] [Abstract][Full Text] [Related]
4. Ginseng polysaccharides enhanced ginsenoside Rb1 and microbial metabolites exposure through enhancing intestinal absorption and affecting gut microbial metabolism.
Shen H; Gao XJ; Li T; Jing WH; Han BL; Jia YM; Hu N; Yan ZX; Li SL; Yan R
J Ethnopharmacol; 2018 Apr; 216():47-56. PubMed ID: 29366768
[TBL] [Abstract][Full Text] [Related]
5. Comparative Analysis of the Rats' Gut Microbiota Composition in Animals with Different Ginsenosides Metabolizing Activity.
Dong WW; Xuan FL; Zhong FL; Jiang J; Wu S; Li D; Quan LH
J Agric Food Chem; 2017 Jan; 65(2):327-337. PubMed ID: 28025886
[TBL] [Abstract][Full Text] [Related]
6. Gut microbiota in the pharmacokinetics and colonic deglycosylation metabolism of ginsenoside Rb1 in rats: Contrary effects of antimicrobials treatment and restraint stress.
Kang A; Zhang S; Zhu D; Dong Y; Shan J; Xie T; Wen H; Di L
Chem Biol Interact; 2016 Oct; 258():187-96. PubMed ID: 27613481
[TBL] [Abstract][Full Text] [Related]
7. Intestinal bacterial hydrolysis is required for the appearance of compound K in rat plasma after oral administration of ginsenoside Rb1 from Panax ginseng.
Akao T; Kida H; Kanaoka M; Hattori M; Kobashi K
J Pharm Pharmacol; 1998 Oct; 50(10):1155-60. PubMed ID: 9821663
[TBL] [Abstract][Full Text] [Related]
8. Ginsenoside Rb1, Compound K and 20(S)-Protopanaxadiol Attenuate High-Fat Diet-Induced Hyperlipidemia in Rats via Modulation of Gut Microbiota and Bile Acid Metabolism.
Zhang KX; Zhu Y; Song SX; Bu QY; You XY; Zou H; Zhao GP
Molecules; 2024 Mar; 29(5):. PubMed ID: 38474620
[TBL] [Abstract][Full Text] [Related]
9. Ginsenoside Rb1 and its metabolite compound K inhibit IRAK-1 activation--the key step of inflammation.
Joh EH; Lee IA; Jung IH; Kim DH
Biochem Pharmacol; 2011 Aug; 82(3):278-86. PubMed ID: 21600888
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of antidiabetic and synergistic effects of ginseng polysaccharide and ginsenoside Rb1 on diabetic rat model.
Li J; Li R; Li N; Zheng F; Dai Y; Ge Y; Yue H; Yu S
J Pharm Biomed Anal; 2018 Sep; 158():451-460. PubMed ID: 30032757
[TBL] [Abstract][Full Text] [Related]
11. Gut microbiota-mediated pharmacokinetics of ginseng saponins.
Kim DH
J Ginseng Res; 2018 Jul; 42(3):255-263. PubMed ID: 29983606
[TBL] [Abstract][Full Text] [Related]
12. Transformation of ginseng saponins to ginsenoside Rh2 by acids and human intestinal bacteria and biological activities of their transformants.
Bae EA; Han MJ; Kim EJ; Kim DH
Arch Pharm Res; 2004 Jan; 27(1):61-7. PubMed ID: 14969341
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of ginsenoside R(c) by human intestinal bacteria and its related antiallergic activity.
Bae EA; Choo MK; Park EK; Park SY; Shin HY; Kim DH
Biol Pharm Bull; 2002 Jun; 25(6):743-7. PubMed ID: 12081140
[TBL] [Abstract][Full Text] [Related]
14. Metabolism of ginsenoside Re by human intestinal microflora and its estrogenic effect.
Bae EA; Shin JE; Kim DH
Biol Pharm Bull; 2005 Oct; 28(10):1903-8. PubMed ID: 16204943
[TBL] [Abstract][Full Text] [Related]
15. Hepatoprotective effect of ginsenoside Rb1 and compound K on tert-butyl hydroperoxide-induced liver injury.
Lee HU; Bae EA; Han MJ; Kim NJ; Kim DH
Liver Int; 2005 Oct; 25(5):1069-73. PubMed ID: 16162168
[TBL] [Abstract][Full Text] [Related]
16. Constitutive beta-glucosidases hydrolyzing ginsenoside Rb1 and Rb2 from human intestinal bacteria.
Bae EA; Park SY; Kim DH
Biol Pharm Bull; 2000 Dec; 23(12):1481-5. PubMed ID: 11145182
[TBL] [Abstract][Full Text] [Related]
17. Metabolic activities of ginseng and its constituents, ginsenoside rb1 and rg1, by human intestinal microflora.
Choi JR; Hong SW; Kim Y; Jang SE; Kim NJ; Han MJ; Kim DH
J Ginseng Res; 2011 Sep; 35(3):301-7. PubMed ID: 23717073
[TBL] [Abstract][Full Text] [Related]
18. Prebiotics enhance the biotransformation and bioavailability of ginsenosides in rats by modulating gut microbiota.
Zhang X; Chen S; Duan F; Liu A; Li S; Zhong W; Sheng W; Chen J; Xu J; Xiao S
J Ginseng Res; 2021 Mar; 45(2):334-343. PubMed ID: 33841014
[TBL] [Abstract][Full Text] [Related]
19. Significant difference in active metabolite levels of ginseng in humans consuming Asian or Western diet: The link with enteric microbiota.
Wan JY; Wang CZ; Zhang QH; Liu Z; Musch MW; Bissonnette M; Chang EB; Li P; Qi LW; Yuan CS
Biomed Chromatogr; 2017 Apr; 31(4):. PubMed ID: 27606833
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic Profiling of Ginsenosides, Rb1, Rd, and Rg3, in Mice with Antibiotic-Induced Gut Microbiota Alterations: Implications for Variability in the Therapeutic Efficacy of Red Ginseng Extracts.
Kim JK; Choi MS; Park HS; Kee KH; Kim DH; Yoo HH
Foods; 2023 Dec; 12(23):. PubMed ID: 38231867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
